Latest Resources

Is South Africa in the US WTO Sights Over GM Import Ban?

Opinion And Analysis: By Mariam Mayet, August 2006 South Africa’s ban on GM import approvals South Africa’s pro-genetic engineering (GE) stance is well documented[1] and enshrined in national government policy. [2] During the period 2001-4, South Africa’s Executive Council (ExCo)[3] established under the Genetically Modified Organisms Act (GMO Act) has allowed the importation into South […]

South Africa’s ban on GM import approvals

In September/October 2005, at the behest of the Department of Trade and Industry (DTI), the Executive Council (EC): GMO Act took the decision not to approve any more new GM applications for the purposes of importation in South Africa as food, feed and processing. The decision was taken to accommodate serious concerns by the DTI […]

Can the poor help GM crops? Technology, Representation, and Cotton in the Makhathini Flats

The adoption of Genetically Modified (GM) cotton in South Africa’s Makhathini Flats in 1998 was heralded as a case in which agricultural biotechnology could benefit smallholder farmers, and a model for the rest of the continent to follow. Using historical, political economic and ethnographic data, we find the initial enthusiasm around GM technology to be […]

Article 18(2)(a): The Trojan Horse of the Biosafety Protocol

Read the article here. By Mariam Mayet African Centre for Biosafety July 2006 The “may contain” labels flood the feed sector. Even transboundary movements which could pass as GM-free under existing legislation for LMO-FFPs are labelled as “may contain”. Grain trade and important ports are leading in this clever move which actually ridicules the Protocol. […]

Pharma Crops and GE Vaccines

HIV Vaccine Clinical Trial Of Genetically Modified Organism (MRKAd5 HIV1 gag/pol/nef) African Centre for Biosafety Jun 2006. Read here. The Status Of Genetically Modified (gm) Pharmaceutical Crop Research In South Africa Mar 2006 Rose Williams. Read here.

Bioethanol-Maize / Syngenta

COMMENTS BY THE AFRICAN CENTRE FOR BIOSAFETY AND THE CENTRE FOR FOOD SAFETY (USA) Comments on Syngenta’s Application for Commodity Clearance of Genetically Modified Maize, Event 3272 African Centre for Biosafety & Centre for Food Safety, 29 May 2006 Read here. OVERVIEW Syngenta’s Event 3272 maize represents the very first genetically modified (GM) industrial crop […]

South Africa, Bioethanol and GMOs: A Heady Mixture

On the 12th of May 2006 Syngenta South Africa (Pty) Ltd, a subsidiary of Swiss chemical giant Syngenta, notified the public of its intention to seek commodity clearance for its GM maize for the use in the production of ethanol. This is the first GM application for commercial approval in the world for a non-feed, […]

The status of Genetically Modified (GM) pharmaceutical crop research in South Africa

Genetically modified (GM) pharmaceutical crops are crops which have been genetically engineered / modified to produce pharmaceuticals. These pharmaceuticals can be vaccines, anti-bodies or therapeutic proteins. Pharma-crops (as they are known) are a contested and little-known terrain, with remarkable benefits being claimed for them in South Africa. Other voices ask about the contamination of the […]

Out of Africa: Mysteries of access and benefit sharing

In late 2005 the Edmunds Institute and the African Centre for Biosafety contacted famed bio-pirate hunter Jay McGowan to investigate incidences of access and benefit sharing in Africa. Despite many constraints on the research, McGowan found a plethora of incidents where transnational corporations had utilised African biodiversity without concluding benefit sharing agreements with the local […]

Biohazard Map of GM Field Trials in SA

Now that the dust is settling after industry’s aggressive PR hype about the unsubstantiated increase in South Africa’s GM commercial plantings for 2006, we bring to you, based upon empirical data, a short briefing paper on the field trials of GMOs grown in South Africa during 2006, compiled by ACB researcher, Rose Williams. This briefing […]